Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
CalScreener assay provides increased throughput to detect tumorous micro tissues, bacteria and parasitic worms
Life Science Competitiveness Indicators compare performance of UK on global life science stage
The availability of high-quality surplus equipment is increasing at the same time that CDMOs are expanding to meet growing demand. Matt Hicks, COO, Federal Equipment Company, discusses the benefits of strategies to manage used equipment
Expands orphan drug business with the addition of two treatments for rare metabolic conditions
To advance Anticalin-based therapeutic for inhaled delivery to treat asthmatics
Western blotting methods have changed little in 30 years. But this technique has traditionally been restricted by issues of variability. Mats Falk, GE Healthcare Life Sciences, argues that new technologies and detection techniques herald a new era
Comments are invited up to 30 June 2015
Antibody-drug conjugates have provided a breakthrough in targeted medicines but ways of increasing their stability and efficacy are still required. Catalent highlights how these goals can be achieved using its SMARTag technology platform to produce site-specific ADCs
Reinforces leadership position in CNS
To meet changing business models and complex regulation, Diane Palmquist, VP, Manufacturing Industry Solutions at GT Nexus argues that supply chain visibility has to see fundamental change too
Generating Antibiotic Incentives Now (GAIN) Act is expected to reduce barriers to market entry
At a recent EMA workshop held in London to discuss the lack of progress on Alzheimer’s therapies, drug developers highlighted the hurdles faced in meeting standards for drug approval